Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Daré Bioscience, Inc. on the transaction, and Gibson, Dunn & Crutcher advised XOMA (US) LLC. Daré Bioscience, Inc....
Daré Bioscience’s $22 Million Non-Dilutive Strategic Royalty Financing
Immusoft’s Research Collaboration and Licensing Agreement With Takeda
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Immusoft on the deal. Immusoft, a cell therapy company dedicated to improving the lives of patients with rare...
Nuvve’s $750 Million Joint Venture with Stonepeak Partners LP
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Nuvve on the deal, while Kirkland & Ellis counseled Stonepeak Partners. Nuvve Holding Corp. (Nuvve) (Nasdaq: NVVE), a...